Hypera Stock

Hypera Capital Intensity

The Capital Intensity Ratio of Hypera (HYPE3.SA) as of Aug 20, 2026 is 326.76 %. In the previous year, Capital Intensity Ratio was 329.99 % — a change of -0.98% (lower).

Capital Intensity

326.76 %

YoY

-0.98%

Last updated:

Capital Intensity Ratio of Hypera is 2026 326.76 % . Capital Intensity Ratio of Hypera was 2025 329.99 % . It decreases by -0.98% lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

Capital Intensity Ratio of Hypera is 326.76 % in 2026.

Capital Intensity Ratio of Hypera changed from 329.99 % to 326.76 %, representing a -0.98% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Hypera since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Hypera with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

Profitability — Hypera

All Key Metrics — Hypera